Skip to main content

Page last checked

Goal

Peptides for skin

Sellers offer three peptides on this site for skin. The one with the most research behind it is a cream ingredient, not an injection.

Source: Based on 3 compound guides · checked 2026-08-13

That distinction decides most of this page. A molecule studied on the surface of the skin for thirty years tells you very little about the same molecule in a syringe. The dose is different, the route is different, and what reaches the tissue is different.

Most searches for skin peptides mean cosmetic ingredients in creams and serums. This comparison instead covers three compounds sold as vials; topical skincare peptides are covered separately.

At a glance

Compounds covered

3

With published human dosing

1 of 3

Approved or being tested for this

0

No human evidence for this goal

2

Three compounds, and what was tested on skin

The right column separates work done on the surface of the skin from work done with a needle. For the compound people buy most, almost all of it is the first kind.

◆ 3 compounds coveredsources shown in each row
Compounds people take for this purpose, why they use them, what human research has measured, and where the evidence comes from.
CompoundWhat people take it forWhat research showsEvidence
GHK-CuSold for wrinkles, firmness and scars, and for hair regrowth — increasingly as an injection rather than a cream.Reported use onlyAlmost everything published is a cream on the surface of the skin. Where that work was blinded and measured objectively, the copper peptide did no better than its control. A 2026 review of injectable peptides states that the dose, the frequency and the reasons for injecting this one all remain unknown.indirect evidenceNo human dose published
KPVSold for eczema and other inflamed skin, and for gut inflammation alongside it.Reported use onlyThe interest behind it is real and narrow. In mice given colitis chemically, and in colon cells in a dish, it quietens inflammatory signaling. FDA states it has found no data on any person receiving it, by any route.no human dose shown to workNo human dose published
LL-37Sold for stubborn skin infections and biofilms, on its natural role in the skin’s own defenses.Measured in a human studyIt has reached people twice in registered work, and one of those was skin. On venous leg ulcers the two lower strengths improved healing while the highest did no better than placebo. FDA cited animal findings of harm to male reproduction and of tumor-promoting activity in some tissues.limited human dataDose from a human trial · no FDA label

1 rests on a human study that measured something in this goal. 2 rest on reported use alone, with no study behind them.

The cosmetic clearance is not evidence, and it is doing the selling

GHK-Cu is a known cosmetic ingredient under the name copper tripeptide-1. That framework asks whether an ingredient is safe on skin. It does not ask whether it works, and it does not ask anything at all about a needle.

So the strongest-sounding fact about the most-bought skin peptide is a statement about creams. It is a recognized, long-used skin ingredient, and the product riding on that fact is a vial. One US regulator has looked at the injection specifically, and FDA’s entry covers injectable routes explicitly.

The plainest evidence on this page cuts against the pitch. When researchers tested the copper peptide blind against a control and measured it objectively, it did not win. That result is thirty years old and nobody has overturned it.

Nobody has published an injected skin dose

For all three rows, no study has set a quantity to inject for a skin purpose. The LL-37 work that reached skin used a preparation put on an ulcer or into a tumor deposit, at strengths chosen for those settings.

KPV has no published human evidence. FDA looked for exposure data and found none; that is different from a human study finding no effect.

Where to go next

Peptide serums: the result belongs to the formula

A named ingredient is not evidence that every product containing it performs alike.

The grid of 32 compounds against 10 goals

32 compounds appear on at least one page here, and the grid shows on what basis each one does.

The testosterone table, basis by basis

Compare why people use each compound with what human studies have actually measured for testosterone.

Weight loss: the page beside the pitch

Approval, a positive trial and a product are three different things.

What KPV is, how it is used, and what has been studied

KPV is an alpha-msh c-terminal tripeptide (research compound).

LL-37 research, dosing, and approval status

No regulator has approved LL-37; the guide separates human studies from reported use.

How GHK-Cu differs from the rest of its class

No published human dosing schedule was found for GHK-Cu.

Healing and recovery: the page beside the pitch

The confidence runs opposite to the evidence.

Every purpose covered this way is listed on the index of goals people buy peptides for.

13primary sources, each with the day we read it — open the documents used on this page